Robyn Beckwith

Robyn Beckwith is a Senior Principal Scientist in Technical Development at Genentech, a member of the Roche Group. She has a strong academic background, having earned her Ph.D. in Molecular and Cell Biology from the University of California, Berkeley in 2008.13

In her role at Genentech, Dr. Beckwith specializes in Analytical Development and Quality Control, focusing on the development and validation of assays for pharmacokinetics (PK) and immunogenicity assessment. Her expertise encompasses a variety of biotherapeutic modalities, including monoclonal antibodies and gene therapies.12

Throughout her career, she has been involved in significant regulatory filings during the preclinical and clinical development of biopharmaceutical products and has contributed to multiple publications in the field.12 Dr. Beckwith's work is crucial in ensuring the safety and efficacy of new therapeutics, particularly in the context of immunogenicity prediction and control.12

For more detailed insights into her professional journey, you can refer to her LinkedIn profile here .4